Transglutaminase is a calcium-activated enzyme that crosslinks substra
te proteins into insoluble, often filamentous aggregates resistant to
proteases. Because the neurofibrillary tangles in Alzheimer's disease
have similar characteristics, and because tau protein, the major compo
nent of these tangles is an excellent substrate of transglutaminase in
vitro, transglutaminase activity and levels were measured in control
and Alzheimer's disease brain. Frozen prefrontal cortex and cerebellum
samples from Alzheimer's disease and control cases matched for age an
d postmortem interval were used in the analyses. Total transglutaminas
e activity was significantly higher in the Alzheimer's disease prefron
tal cortex compared to control. In addition the levels of tissue trans
glutaminase, as determined by quantitative immunoblotting, were elevat
ed approximately 3-fold in Alzheimer's disease prefrontal cortex compa
red to control. To our knowledge, this is the first demonstration that
transglutaminase is increased in Alzheimer's disease brain. There wer
e no significant differences in transglutaminase activity or levels in
the cerebellum between control and Alzheimer's disease cases. Because
the elevation of transglutaminase in the Alzheimer's disease samples
occurred in the prefrontal cortex, where neurofibrillary pathology is
usually abundant, and not in the cerebellum, which is usually spared i
n Alzheimer's disease, it can be suggested that transglutaminase could
be a contributing factor in neurofibrillary tangle formation.